This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a McGill University directory, so their publications, courses and email address may be missing. Find their university profile.
Latest funding
- $1,683,000
An international platform for finding the optimal therapies for Pneumocystis jirovecii pneumonia: The PCP Platform
CIHR · 2024 · Co-investigator
- $539,325
Clopidogrel vs. Aspirin in S. aureus Bacteremia (Clopido-SNAP)
CIHR · 2024 · Co-investigator
- $539,325
Dabigatran for the adjunctive treatment of Staphylococcus aureus bacteremia: the DABI-SNAP nested randomized controlled trial
CIHR · 2024 · Co-investigator
An international platform for finding the optimal therapies for Pneumocystis jirovecii pneumonia: The PCP Platform
Principal investigators: Lee, Todd C; Benedetti, Andrea; Bhagani, Sanjay; Boyles, Tom; Butler-Laporte, Guillaume; Cheng, Matthew P; McDonald, Emily G; McGuinty, Michaeline; Nakashima, Kei; Schwartz, Ilan S; Slavin, Monica; So, Miranda; Tan, Darrell H; Yong, Michelle
Keywords: Immunomodulation; Platform Trial; Pneumocystis; Pneumonia; Randomized Controlled Trial; Secondary Prophylaxis; Treatment
Clopidogrel vs. Aspirin in S. aureus Bacteremia (Clopido-SNAP)
Principal investigators: Lee, Todd C; Cheng, Matthew P; Daneman, Nick; Davis, Joshua; Goodman, Anna L; Lawler, Patrick R; McDonald, Emily G; Mertz, Dominik; Paul, Mical; Siegal, Deborah M; Tong, Steven; Walls, Genevieve
Keywords: Antithrombotic Therapy; Bacteremia; Randomized Controlled Trial; Staphylococcus Aureus
Dabigatran for the adjunctive treatment of Staphylococcus aureus bacteremia: the DABI-SNAP nested randomized controlled trial
Principal investigators: McDonald, Emily G; Cheng, Matthew P; Daneman, Nick; Davis, Joshua; Goodman, Anna L; Lawandi, Alexander; Lawler, Patrick R; Lee, Todd C; Mertz, Dominik; Paul, Mical; Siegal, Deborah M; Tong, Steven; Walls, Genevieve
Keywords: Adjunctive Therapies; Anticoagulants; Comparative Effectiveness Trial; Desirability Of Ordinal Outcomes Rating; Infectious Diseases; Nested Trials; Platform Trial; Pragmatic Trials; Staph Aureus Bacteremia
A Randomized Controlled Trial of Oral Antimicrobial Therapy for Patients with Staphylococcus aureus Bacteremia: The Early Oral Switch Domain in the Staphylococcus aureus Network Adaptive Trial (EOS-SNAP)
Principal investigators: Cheng, Matthew P; Bai, Anthony D; Daley, Peter; Daneman, Nick; Grant, Jennifer; Lawandi, Alexander; Lee, Todd C; MacFadden, Derek R; McDonald, Emily G; Somayaji, Ranjani; Wuerz, Terence
Keywords: Bacteremia; Bloodstream Infection; Clinical Trial; Oral Antibiotics; Staphylococcus Aureus
Expanding the Staphylococcus Aureus Network Adaptive Platform (SNAP^2)
Principal investigators: Lee, Todd C; Cheng, Matthew P; Daneman, Nick; Davis, Joshua; Goodman, Anna L; Johnstone, Jennie; Lawandi, Alexander; Lye, David C; McDonald, Emily G; Paul, Mical; Tong, Steven; Walls, Genevieve; Wuerz, Terence
Keywords: Combination Therapy; Endocarditis; Randomized Controlled Trial; Staphylococcus Aureus Bacteremia
Expanding the Staphylococcus Aureus Network Adaptive Platform (SNAP^2)
Principal investigators: Lee, Todd C; Cheng, Matthew P; Daneman, Nick; Davis, Joshua; Goodman, Anna L; Johnstone, Jennie; Lawandi, Alexander; Lye, David C; McDonald, Emily G; Paul, Mical; Tong, Steven; Walls, Genevieve; Wuerz, Terence
Keywords: Combination Therapy; Endocarditis; Randomized Controlled Trial; Staphylococcus Aureus Bacteremia
The S. aureus Network Adaptive Platform Trial (SNAP) Canada: A Randomized Controlled Trial for Penicillin-susceptible, Methicillin-susceptible, and Methicillin-resistant Staphylococcus aureus Bloodstream Infections in Hospitalized Patients
Principal investigators: Cheng, Matthew P; Daneman, Nick; Johnstone, Jennie; Lee, Todd C
Keywords: Bacteremia; Randomized Controlled Trial; Staphylococcus Aureus
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.